(Q33827578)

29 July 2017

1 reference

title

Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors (English)

1 reference

29 July 2017

Tisdale M

1

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Reviews in Medical Virology

29 July 2017

published in

1 reference

29 July 2017

volume

10

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

45-55

1 reference

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Rapid development of drug-resistant mutants of poliovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

The selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Reproduced from Proc. Natl. Acad. Sci. USA 74, 5716-5720 (1977)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Sensitivity of herpes virus isolates from acyclovir clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Use of antivirals in influenza in the elderly: prophylaxis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

The broad spectrum antiviral agent ribavirin inhibits capping of mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Determination of ribonucleoside triphosphate pools in influenza A virus-infected MDCK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Influenza virus neuraminidase: structure, antibodies, and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Predicting and preventing the emergence of antiviral drug resistance in HSV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Prophylaxis of smallpox with methisazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

CELL CULTURE STUDIES ON ANTIVIRAL AGENTS. I. ACTION OF CYTOSINE ARABINOSIDE AND SOME COMPARISONS WITH 5-IODO-2-DEOXYURIDINE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

In vivo Selection of an Influenza A2 Strain resistant to Amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

The matrix protein gene determines amantadine-sensitivity of influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

Influenza virus resistance to neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R

10.1002/(SICI)1099-1654(200001/02)10:1<45::AID-RMV265>3.0.CO;2-R

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference